Lisinopril And Hydrochlorothiazide
Product Images NDC 67296-1691

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lisinopril And Hydrochlorothiazide (NDC 67296-1691). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Linisopril Hctz 67296 1691)

Label for Lisinopril and Hydrochlorothiazide 10 mg / 12.5 mg tablets, package of 30, labeled as Rx only. Manufactured by Watson Pharma Private Limited in India and distributed by RedPharm Drug, Inc. in Eden Prairie, MN. Includes lot number and expiration date fields along with barcodes and storage instructions.*

FDA Label Image

Structural Formula Of Lisinopril (Image 1)

Chemical structure of Lisinopril, showing its molecular configuration including rings, side chains, and functional groups, with water of hydration indicated (2H2O).*

FDA Label Image

Structural Formula Of Hydrochlorothiazide (Image 2)

Chemical structure of the active ingredient, shown as a ringed molecular diagram with labeled chemical groups including NH2SO2, Cl, and sulfonyl groups. This image corresponds to the structural depiction of one of the components of the drug product Lisinopril and Hydrochlorothiazide by RedPharm Drug, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.